Skip to content

Surgical Outcome Of da Vinci Single-port Surgical System In Lung Cancer

Surgical Outcome Of da Vinci Single-port Surgical System In Lung Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07790406
Enrollment
50
Registered
2026-08-27
Start date
2026-02-02
Completion date
2032-12-01
Last updated
2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer (NSCLC)

Keywords

lung cancer, surgery

Brief summary

Early-stage lung cancer represents a clinical challenge that, when diagnosed promptly, offers high chances of cure through lobectomy and lymphadenectomy. In addition to traditional surgery, robotic techniques have become established and have recently evolved further with the Single-Port system, which allows the procedure to be performed through a single subcostal incision rather than multiple openings between the ribs. This approach reduces invasiveness, postoperative pain, and recovery time, while maintaining the same oncological effectiveness and safety as standard techniques. This is a monocentric and non-profit collection of clinical data, both prospective and retrospective, from patients treated with this method, ensuring data privacy through coded information and compliance with current regulations; the study is independent and non-profit.

Interventions

PROCEDUREda Vinci Single Port

U-RATS lobectomy

Sponsors

European Institute of Oncology
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* all patients with proven non-small cell lung cancer (NSCLC) clinical stage I (9th TNM edition), who have undergone or will undergo lobectomy plus radical lymph node dissection following the STS guide line

Exclusion criteria

* no consent

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of experience"From enrollment to the end of 5 year follow-upThe objective of this study is to collect and describe IEO experiences in the use of the Da Vinci SP surgical system for anatomical lung resection.

Countries

Italy

Contacts

CONTACTMonica Casiraghi, MD PhD
monica.casiraghi@ieo.it025748662

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 28, 2026